Review of Carcinoid Syndrome: what is is and how it is treated by Joel George et al (Hampshire Hospitals and Kings Healthcare Partners ENETs Centre of Excellence) Online Publication Date: 19 Jun 2023 Neuroendocrine Cancers (aka neuroendocrine neoplasms or NENs) may...
Neuroendocrine Cancer UK Announces Partnership with RareCan to help Facilitate Access to Clinical Trial Opportunities Neuroendocrine Cancer UK is excited to announce a partnership with RareCan to help grow cohorts of people with neuroendocrine cancer, empowering them...
Please join us in wishing all the luck in the world to Pete, who along with his family and friends, will be embarking on a cycle ride from the north to the south of Devon tomorrow. You may already be aware of this incredible fundraiser, as Pete has featured in many...
Our wonderful supporter and fundraiser, Pete has been featured in the Plymouth Live! READ HERE ➡️ https://www.plymouthherald.co.uk/news/plymouth-news/plymouth-mans-miracle-fightback-after-6887036 You can support Pete’s cycle here –...
Neuroendocrine Cancers (NETs and NECs) are globally increasing in incidence (those newly diagnosed) and prevalence (those living with Neuroendocrine Cancer). However, many may not be diagnosed until liver metastases (spread) has occurred. Neuroendocrine liver...
